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Abstract
Chlamydial infection of the host cell induces Gamma interferon (IFNc), a central immunoprotector for humans and mice. The
primary defense against Chlamydia infection in the mouse involves the IFNc-inducible family of IRG proteins; however, the
precise mechanisms mediating the pathogen’s elimination are unknown. In this study, we identify Irga6 as an important
resistance factor against C. trachomatis, but not C. muridarum, infection in IFNc-stimulated mouse embryonic fibroblasts
(MEFs). We show that Irga6, Irgd, Irgm2 and Irgm3 accumulate at bacterial inclusions in MEFs upon stimulation with IFNc,
whereas Irgb6 colocalized in the presence or absence of the cytokine. This accumulation triggers a rerouting of bacterial
inclusions to autophagosomes that subsequently fuse to lysosomes for elimination. Autophagy-deficient Atg52/2 MEFs
and lysosomal acidification impaired cells surrender to infection. Irgm2, Irgm3 and Irgd still localize to inclusions in IFNc-
induced Atg52/2 cells, but Irga6 localization is disrupted indicating its pivotal role in pathogen resistance. Irga6-deficient
(Irga62/2) MEFs, in which chlamydial growth is enhanced, do not respond to IFNc even though Irgb6, Irgd, Irgm2 and
Irgm3 still localize to inclusions. Taken together, we identify Irga6 as a necessary factor in conferring host resistance by
remodelling a classically nonfusogenic intracellular pathogen to stimulate fusion with autophagosomes, thereby rerouting
the intruder to the lysosomal compartment for destruction.
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Introduction
Chlamydiae are obligate intracellular pathogens that cause a
variety of infections in humans and animals. Chlamydia trachomatis is
a primarily human pathogen associated with common sexually
transmitted diseases and trachoma [1]. Chlamydiae undergo a
unique biphasic developmental cycle that alternates between
extracellular infectious, metabolically inert elementary bodies
(EBs) and the intracellular non-infectious, metabolically active,
multiplying reticulate bodies (RBs) [2,3]. Bacteria enter the host
cell and survive within a membrane-bound vacuole, termed the
inclusion, in which they ensure their successful propagation by
avoiding fusion with lysosomes [4,5]. Non-fusogenity with
lysosomes is controlled by the mode of cellular uptake [6,7] and
chlamydial protein factors [8,9].
Gamma interferon (IFNc) plays a central role in innate
immunity against intracellular pathogens. It induces the expression
of more than 1,200 genes, a number of which include effectors that
function to eradicate pathogens from host cells. Their activation
leads to a depletion of the tryptophan (Trp) pool [10], production
of toxic nitric oxide [11], deprivation of intracellular iron pools
[12] and induction of host autophagy [13,14]. Among the genes
highly induced by IFNc are the immunity-related GTPases (IRGs;
also known as small p47 GTPases), reviewed in [1,15–18].
Recent work has indicated the involvement of several mouse
IRG proteins in the growth regulation of pathogens within IFNc-
induced host cells: for instance, Irgm1 stimulates IFNc-induced
control of Mycobacterium tuberculosis and Trypanosoma cruzi in
macrophages [19] and Irgm3 regulates IFNc-induced control of
C. trachomatis in fibroblasts [20]. Irgm3-, Irgd- and Irgm1-knockout
mice displayed reduced resistance to several bacterial and
protozoan pathogens despite an immune response and IFNc
production [21,22]. This strong correlation between loss of
resistance in intact mice and loss of IFNc-induced control in
cultured host cells suggests eliminating pathogens from host cells is
a major function of these proteins.
IRG proteins localize predominantly to the endoplasmic
reticulum (ER) (Irga6 and Irgm3), the Golgi (Irga6, Irgm1 and
Irgm2), the plasma membrane and in nascent pathogen-containing
vacuoles or phagosomes [reviewed in 16–18]. The localization of
IRGs to pathogen-containing vacuoles in host cells suggests that
they restrict pathogen growth by vacuole processing. IRGs have
been shown to drive vacuole acidification and fusion with lysosomes
in M. tuberculosis [19], to disrupt the vacuolar membrane in
Toxoplasma gondii [23,24] and to eliminate mycobacteria containing
vacuoles through regulating IFNc-induced autophagy [13,14].
Autophagy is an evolutionary conserved lysosomal degradation
pathway that maintains cellular homeostasis and selectively
PLoS ONE | www.plosone.org 1 February 2009 | Volume 4 | Issue 2 | e4588disposes of intracellular pathogens [13,25,26]. Not only intracel-
lular pathogens residing in the cytosol, but also pathogens residing
in membranous or intravacuolar compartments are sequestered
into autophagosomes for degradation in autolysosomes, as shown
for T. gondii [23,27].
Chlamydiae exhibit a wide range of host tropism that has been
linked to differences in immune responses elicited by IFNc [28]. In
human cells, IFNc can effectively suppress growth of C. trachomatis
and C. muridarum by activating indolamine dioxygenase, which
deprives both of essential Trp. However, in murine genital
epithelial cells (MECs), IFNc can restrict growth of C. trachomatis,
but not C. muridarum [28]. Growth inhibition of C. trachomatis in
mouse cells is Trp depletion independent and is largely attributed
to the IFNc-inducible IRGs. Little is known about the cellular
functions of mouse IRGs in host resistance against Chlamydia
species. A role for Irga6 in controlling pathogen growth upon
IFNc stimulation in MECs was demonstrated by RNA silencing of
Irga6, which led to increased C. trachomatis survival [28]. However,
the major effector mechanism(s) by which IRGs control chlamyd-
ial infection remain elusive.
Here we investigated the immunoprotective role of IRGs in C.
trachomatis infection of murine cells and in the IFNc-insensitive
mouse strain C. muridarum. We show that C. trachomatis growth is
arrested by the development of early inclusions with autolysosomal
features. In contrast, C. muridarum inclusions remained segregated
from lysosomes and autophagosomes. Subcellular analysis re-
vealed that C. trachomatis inclusions sequestered Irga6, Irgd, Irgm2
and Irgm3 in response to IFNc blocking chlamydial growth.
However, autophagy-deficient cells tolerated C. trachomatis infec-
tion despite an accumulation of Irgd, Irgm2 and Irgm3 at
inclusions. Strikingly, Irga6 did not associate with inclusions in
autophagy-deficient cells. In addition, Irga62/2 MEFs did not
respond to IFNc and did not restrict C. trachomatis growth,
although Irgd, Irgm2 and Irgm3 localized to inclusions. Thus, our
data indicate that Irga6 modifies the inclusion membrane to
mediate fusion with autophagosomes as a mechanism to dispose of
C. trachomatis.
Results
IFNc negatively affects the growth of C. trachomatis, but
not of C. muridarum in MEFs
IFNc is a critical mediator for controlling chlamydial infection.
To assess the effect of IFNc on chlamydial growth in mouse
embryonic fibroblasts (MEFs), cells were infected with C. trachomatis
LGV L2 or C. muridarum at a multiplicity of infection (MOI) of 1
for 2 h. Following 48 h incubation in the presence of IFNc, cells
were immunostained and analyzed by microscopy. IFNc treat-
ment resulted in much smaller and substantially reduced numbers
of C. trachomatis inclusions (Figure 1A). Similar results were
obtained from the pretreated cells with IFNc. Furthermore, a
reduction of infectious C. trachomatis EBs of more than 70% as
compared to non-treated infected MEFs (Figure 1B) was found. In
contrast, IFNc affected neither inclusion development nor
formation of infectious progeny of C. muridarum (Figure 1C and
D). Thus, distinct chlamydial species exhibit differential sensitiv-
ities to IFNc in host resistance: Growth of C. trachomatis in MEFs is
arrested in response to IFNc, whereas growth of C. muridarum is not
affected in response to IFNc.
Irga6, Irgd, Irgm2 and Irgm3 interact specifically with
early C. trachomatis inclusions in response to IFNc
Since IFNc can upregulate IRG expression in C. trachomatis
infected murine cells [28], we investigated the involvement of
IRGs in IFNc-mediated inhibition of chlamydial growth. Un-
treated and IFNc-pretreated MEFs were infected with C.
trachomatis or C. muridarum (MOI 5) in the presence of IFNc.
Three hours post infection (h p.i.) cells were processed for indirect
immunofluorescence to analyze colocalization of early chlamydial
inclusions with IRGs (Figure 2A). Upon IFNc treatment C.
trachomatis inclusions colocalized to a high degree with IRGs: Irga6
(83%), Irgd (49%), Irgm2 (74%) and Irgm3 (87%). Surprisingly,
Irgb6 also colocalized with inclusions in both treated (63%) and
untreated cells, whereas Irgm1 colocalization was minimal
(Figure 2B). However, no localization of IRGs to C. muridarum
inclusions was detected (Figure S1A). Thus, IFNc stimulation leads
to a specific modification of C. trachomatis inclusions by recruiting
four different IRGs.
IFNc stimulates C. trachomatis elimination by lysosomal
fusion with early inclusions
We next investigated whether IRG-positive C. trachomatis
inclusions are directed to lysosomes for degradation. First we
monitored colocalization of inclusions with the lysosomal marker
LAMP1 at 3 h p.i. In control, untreated MEFs, only 20% of
inclusions colocalized with LAMP1. In contrast, LAMP1 coloca-
lization in inclusions of IFNc-treated cells was increased 4-fold
(Figure 3A and B). Consistent with an ability to grow in the
presence of IFNc, no LAMP1 colocalization with C. muridarum
inclusions was observed in untreated or IFNc-treated cells (Figure
S2A and B). To confirm that IFNc-induced phagosome-lysosome
fusion eliminates C. trachomatis, we studied the effect of inhibiting
lysosomal acidification with bafilomycin A1 (Baf A1), a specific
vacuolar H
+-ATPase inhibitor. Growth of C. trachomatis inclusions
was rescued and formation of infectious EBs increased upon Baf
treatment (Figure 3C and D). These data clearly indicate that
lysosomal fusion elicited by IFNc eliminates chlamydial inclusions.
IFNc-induced autophagy is required for the elimination
of C. trachomatis
IFNc can induce autophagy to eliminate intracellular pathogens
[13,14]. We hypothesized that IFNc induces the interaction of C.
trachomatis inclusions with autophagosomes to reroute the intruder
to the lysosomal compartment for destruction; therefore, we
transfected MEFs with the autophagosome-associated marker
GFP-LC3, a GFP fusion with the microtubule-associated protein
light chain 3 (LC3). Then, MEFs were either infected with C.
trachomatis or C. muridarum in the presence or absence of IFNc.I n
contrast to IFNc-untreated cells, GFP-LC3 colocalized strongly to
C. trachomatis inclusions (74%) in IFNc treated cells (Figure 3E and
F). However, minimal GFP-LC3 colocalization was observed in C.
muridarum inclusions (Figure S2C and D). Taken together with our
LAMP1 data, these findings clearly suggest the nature of C.
trachomatis inclusions upon IFNc stimulation is autolysosomal.
To further support our hypothesis, we used Atg5-deficient
(Atg52/2) MEFs (Atg, autophagy-related). Atg5 is a crucial factor
in autophagosome formation as its deletion prevents their
appearance [29]. We infected Atg52/2 MEFs with either C.
trachomatis or C. muridarum (MOI 1) for 48 h in the presence or
absence of IFNc. IFNc treatment did not affect chlamydial growth
as inclusion size and recovery of infectious progeny in these cells
were comparable to those of untreated knockout cells (Figure 4A
and B) and WT MEFs. The completion of chlamydial develop-
ment in cells devoid of autophagy shows that host cell resistance to
chlamydial inclusions depends on their fusion with autophago-
somes. Furthermore, subcellular analysis of cultures at 3 h p.i. with
LAMP1 revealed that lysosomal fusion is blocked in Atg52/2
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with autophagosomes is a prerequisite for lysosomal degradation.
Association of Irga6 with early chlamydial inclusions is
blocked in Atg52/2 MEFs in response to IFNc
To address the role of IFNc-induced IRGs in the regulation of
C. trachomatis survival, we examined the intracellular distribution of
IRGs at 3 h p.i. in Atg52/2 MEFs. Surprisingly, upon IFNc
stimulation most bacterial inclusions colocalized with Irgd (41%),
Irgm2 (80%) and Irgm3 (79%) (Figure 5A and B); results
comparable to data obtained from IFNc-stimulated WT MEFs
(Figure 2). Strikingly, only 2% of inclusions colocalized with Irga6
(Figure 5B), as compared to 83% in IFNc-treated WT MEFs
(Figure 2B). As expected, IRG proteins did not colocalize with
early inclusions of C. muridarum (Figure S1B). These results strongly
suggest an important role for Irga6 in autophagy-mediated control
of C. trachomatis infection.
Absence of Irga6 stimulates growth of C. trachomatis and
induces resistance against IFNc-induced killing
To further analyze the role of Irga6 in IFNc-mediated growth
restriction of C. trachomatis, we examined Irga6-knockout (Irga62/
2) MEFs. Untreated Irga62/2 cells infected for 48 h with C.
trachomatis generated larger inclusions and yielded a 4 to 5-fold
increase in the number of infectious progeny, compared to
untreated WT cells (Figure 6A and B). IFNc treatment did not
inhibit the growth of inclusions in Irga62/2 cells, but they were
bigger than in control untreated WT MEFs (Figure 6A).
Surprisingly, infected Irga62/2 MEFs were sensitive to IFNc
exposure, which resulted in partial destruction and loss of infected
host cells of the monolayer. Therefore, the chlamydial infectivity
measured in each sample had to be normalized to the surviving
host cells, determined via an LDH release assay (data not shown).
This data clearly indicated that IFNc treatment of Irga62/2 cells
did not reduce infectivity (Figure 6B).
Figure 1. IFNc-induced inhibition of C. trachomatis growth in WT MEFs. Host cells were infected for 48 h with C. trachomatis or C. muridarum
(MOI 1) and simultaneously treated with 100 U or 200 U/ml IFNc or left untreated (control). (A) and (C) Immunofluorescence micrographs of MEFs
infected with C. trachomatis or C. muridarum, respectively, stained with Chlamydia-IMAGEN kit. Chlamydiae (green), Host cells (red). Cytokine
treatment resulted in a low number of detectable small inclusions in C. trachomatis infected cells only. Images taken using the same magnification. (B)
and (D) Influence of IFNc on development of infectious progeny. The yield of C. trachomatis (B), but not C. muridarum (D), infectious progeny
decreased considerably upon IFNc stimulation, Infectivity percentage calculated as follows: IFU/ml estimated for each treated monolayer / IFU/ml of
control cells 6100. Infectivity expressed as a percentage of control cells 6standard deviation (SD) from three independent experiments (n=3). WT,
wild type; Ctr, C. trachomatis; Cmur, C. muridarum.
doi:10.1371/journal.pone.0004588.g001
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and 5, respectively), IFNc treatment of Irga62/2 MEFs at 3 h
p.i. increased the association of Irgd, Irgm2 and Irgm3 with early
bacterial inclusions (Figure S3A and S3B). As expected, no signal
for Irga6 was detected in IFNc-exposed or unexposed Irga6-
deficient MEFs (Figure S3A). In contrast, no IRG proteins
localized to C. muridarum inclusions (Figure S1C).
Next, we investigated whether enhanced propagation of C.
trachomatis in Irga62/2 MEFs was connected with a lack of
autolysosomal features of inclusions. Indeed, IFNc treatment of
Irga62/2 MEFs did not induce an association of LAMP1 with
chlamydial inclusions (Figure 6C and D). Numbers of bacteria
colocalizing with LAMP1 in IFNc induced Irga62/2 cells were
comparable to untreated WT MEFs (Figure 6C and D).
Consistently, only approximately 1% of bacterial inclusions
colocalized with GFP-LC3 in Irga62/2 cells. These results
indicate that IFNc cannot prevent C. trachomatis development in
cells lacking Irga6. Thus, our data suggest a critical role for Irga6
in provoking anti-chlamydial effects. In contrast, despite their
noticeable association with bacterial inclusions, Irgd, Irgm2 and
Irgm3 do not play a critical role in anti-chlamydial defense. The
loss of Irga6 renders cells incapable of capturing C. trachomatis in an
autolysosome, thus enabling pathogen survival.
Irga6 is important in the induction of autophagy
independent of C. trachomatis infection
Is IFNc capable of activating autophagy in MEFs and is Irga6
required for IFNc-induced autophagy? To answer these questions,
we used immunoblots to monitor the formation of early
autophagosomal precursors and newly formed autophagosomes
by following changes in LC3 expression. LC3 exists in two forms:
the cytosolic LC3-I form, which has a molecular weight of
approximately 18 kDa and the membrane-bound LC3-II form,
with a molecular weight of 16 kDa [30]. LC3-II is bound to the
Figure 2. IFNc triggers accumulation of Irga6, Irgd, Irgm2 and Irgm3 at early inclusions of C. trachomatis. (A) Double
immunofluorescence labelling of IRGs and C. trachomatis in MEFs stimulated for 24 h with 100 U/ml IFNc and then infected for 3 h with C.
trachomatis (MOI 5). IFNc untreated MEFs were similarly infected. Upon IFNc induction Irga6, Irgd, Irgm2 and Irgm3 localized to inclusions. Irgb6
colocalized strongly with inclusions in treated as well as untreated cells, whereas Irgm1 localization was minimal. (B) For quantification, around 300
bacterial inclusions were examined for each IRG in cytokine-treated or untreated MEFs. Colocalization expressed as a mean percentage: for each
treatment, number of IRG +ve inclusions / total number of inclusions 6100. Error bars 6SD, n=3. Scale bar represents 4 mm.
doi:10.1371/journal.pone.0004588.g002
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lacking (Atg52/2) MEFs. (A) Normal development of inclusions (green) was observed in Atg52/2 MEFs (red), despite exposure to either 100 U or
200 U IFNc/ml. Knockout cells were IFNc treated, infected, and stained as in Figure 1. (B) Infectivity titration assays onto fresh HeLa cells revealed
similar amounts of infectious progeny in IFNc-treated and IFNc-untreated Atg52/2 MEFs. Infectivity expressed as a percentage normalized to control
(C) C. trachomatis inclusions avoid interaction with lysosomes in autophagy-defective Atg52/2 MEFs despite IFNc induction. IFNc treated and
untreated Atg52/2 MEFs were infected as in Figure 3A and B. Double immunolabeling demonstrated no recruitment of lysosomes to inclusions
[bacteria (green) and LAMP1 (red)] (D) Quantification of LAMP1-positive chlamydial inclusions revealed insignificant colocalization rates. Around 300
bacterial inclusions were examined. Colocalization expressed as a mean percentage: for each treatment, number of LAMP1 inclusions / total number
of inclusions 6100. Images in (A) were taken under the same magnification, while scale bars in (C) represent 3 mm. Error bars 6SD, n=3.
doi:10.1371/journal.pone.0004588.g004
Figure 3. IFNc stimulation induces interaction of lysosomes and autophagosomes with early C. trachomatis inclusions in MEFs. (A)
and (B) MEF monolayers were prestimulated for 24 h with 100 U/ml IFNc and then infected with C. trachomatis as described in Figure 2. IFNc
untreated control MEFs were similarly infected. (A) Double immunofluorescence labelling 3 h p.i. revealed that IFNc stimulated the association of the
lysosomal marker LAMP1 (red) with C. trachomatis (green) inclusions (compare panel 2 with 1). (B) Percentages of colocalization with LAMP1. (C)
Inhibition of lysosomal acidification by 100 nM Baf A1 stopped the IFNc-mediated inhibition of C. trachomatis inclusion growth. (D) Baf A1 attenuated
the IFNc-induced reduction of C. trachomatis infectivity in MEFs. Infectivity assays were performed as in Figure 1B. Baf A1 led to an increase in the
yield of infectious progeny in IFNc-treated MEFs 48 h p.i. (E) and (F) IFNc induces localization of autophagosomes to inclusions. MEFs were
transfected for 24 h with the autophagosome membrane marker GFP-LC3 and then exposed to 100 U/ml IFNc for an additional 24 h. Next, cells were
infected with C. trachomatis (MOI 5) for 8 h. IFNc-untreated control cells were similarly infected 48 h post-transfection. LC3 (green) localized to
bacterial inclusions (red) in response to IFNc stimulation (compare panel 2 with 1 in E). (F) Quantification of GFP-LC3-positive C. trachomatis inclusions
in the presence or absence of IFNc. Around 300 bacterial inclusions were examined for LAMP1 or LC3 sequestration. Colocalization expressed as a
mean percentage: for each treatment, number of LAMP1 or LC3 +ve inclusions, respectively / total number of inclusions 6100.Scale bars in (A), (C)
and (E) represent 2, 20 and 1 mm, respectively. Error bars 6SD, n=3.
doi:10.1371/journal.pone.0004588.g003
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amount of LC3-positive autophagosomes [30]. In WT cells, LC3-
II levels increased in response to IFNc stimulation (Figure 7A, lane
3). Notably, levels of IFNc-induced LC3-II were comparable to
those induced by rapamycin (Rapa), a conventional inducer of
autophagy (Figure 7A, lane 2). Infection with C. trachomatis for 4 h
or 8 h did not influence LC3-II expression (Figure 7A, lanes 4 and
6, respectively). However, IFNc treatment of infected WT MEFs
induced an upregulation of LC3-II (Figure 7A, lanes 5 and 7). In
general, levels of LC3 protein were substantially lower in Irga62/
2 cells (Figure 7C) as compared to WT MEFs (Figure 7A).
Moreover, IFNc or Rapa treatment had a minimal stimulatory
effect on LC3 expression and/or processing in Irga62/2 cells
(Figure 7C, lanes 2, 3, 5 and 7). C. muridarum infection effectively
suppressed an increase in LC3 levels upon IFNc treatment (Figure
S4A). Similarly, no increase in LC3 levels upon IFNc treatment in
C. muridarum infected Irga62/2 cells (Figure S4C) was observed.
Atg52/2 cells did not process LC3 (Figure 7B and S4B), as
expected for cells that are unable to form autophagosomes [31].
To confirm the importance of Irga6 in autophagy, we quantified
the number of autophagosomes in the cytoplasm. In contrast to
control untreated WT cells (Figure 7D), numbers of GFP-LC3-
decorated structures per cell in infected and uninfected WT cells
exposed to either IFNc or Rapa were increased. In agreement
with our immunoblot analysis, IFNc or Rapa induction did not
increase the amount of autophagosomes and we observed only low
numbers of decorated vesicles in Irga62/2 cells (Figure 7E).
These data further support a pivotal role for autophagy in C.
trachomatis elimination and indicate a role for Irga6 as regulator of
IFNc-induced autophagy.
Figure 5. Absence of Irga6 colocalization at C. trachomatis early inclusions in IFNc stimulated Atg52/2 MEFs. (A) and (B) IFNc treated
and untreated cells were infected with C. trachomatis as in Figure 2. (A) Confocal microscopic analysis of infected stimulated Atg5-knockout cells
shows similar staining patterns for Irgb6, Irgd, Irgm1, Irgm2 and Irgm3 as in stimulated infected WT MEFs (Figure 2). Irga6 does not localize to the
inclusion in IFNc-stimulated and unstimulated Atg5-knockout cells. (B) Quantification of colocalization rates of IRGs with C. trachomatis inclusions.
Around 300 bacterial inclusions were examined. Colocalization expressed as a mean percentage: for each treatment, number of IRG +ve inclusions /
total number of inclusions 6100. Error bars 6SD, n=3. Scale bar represents 4 mm.
doi:10.1371/journal.pone.0004588.g005
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to induce autophagy in nonphagocytic MEFs. More importantly,
low LC3 expression and small numbers of autophagosomes in
Irga62/2 cells indicate a role for Irga6 in the regulation of the
IFNc-induced autophagic pathway. Our results reveal Irga6 as an
important factor in assigning chlamydial inclusions for degrada-
tion via autophagy.
Discussion
Here we elucidate the mechanisms underlying IFNc/IRGs-
induced immunity to C. trachomatis in murine cells, demonstrating a
pivotal role for Irga6 in mediating host resistance to infection via
the induction of autophagy. We show that C. trachomatis, but not C.
muridarum, inclusions strongly colocalized with 4 IRGs (Irga6, Irgd,
Irgm2 and Irgm3) in response to IFNc, whereas Irgb6 colocalized
in the presence or absence of the cytokine. IFNc also induced
accumulation of the autophagosomal membrane marker LC3, and
the lysosomal component LAMP1, suggesting a rerouting of C.
trachomatis phagosomes to autolysosomes. However, autophagy-
deficient MEFs (Atg52/2) and WT cells with an impairment in
lysosomal acidification surrendered to infection. While Irgb6, Irgd,
Irgm2 and Irgm3 still localized to chlamydial inclusions in IFNc-
induced Atg52/2 cells, Irga6 localization was disrupted,
indicating a pivotal role for Irga6 in resistance to the microbe.
Strikingly, Irga6-deficient MEFs (Irga62/2), in which chlamydial
growth is enhanced compared to WT MEFs, showed no response
to IFNc even though all the major IRG proteins studied still
localized to inclusions. Thus, Irga6 constitutes a critical resistance
factor against C. trachomatis infection in IFNc-induced MEFs that
Figure 6. Absence of Irga6 enhances C. trachomatis replication and resistance against IFNc-induced growth inhibition. (A) Deletion of
Irga6 promotes intracellular growth of the bacterial inclusion. Unstimulated WT and Irga6-knockout MEFs were infected for 48 h (MOI 1). Micrographs
show an increased inclusion size in Irga6-knockout cells (panel 3) compared to WT MEFs (panel 1). IFNc (100 U/ml) stimulation did not suppress
chlamydial growth in Irga6-deficient MEFs (panel 4) as in IFNc-induced WT MEFs (panel 2). (B) Infectivity of bacteria in Irga6-knockout MEFs is 4-fold
higher than in WT MEFs and is unaffected by IFNc induction. Results depicted as mean percentage normalized to control. (C) Lack of appreciable
lysosomal fusion with C. trachomatis inclusions in IFNc-stimulated Irga62/2 MEFs (panel 4) unlike that in stimulated WT MEFs (panel 2). Cells were
stimulated, infected and stained for bacteria (green) and LAMP1 (red) as in Figure 3A. Untreated WT and Irga6-knockout monolayers (panels 1 and 3,
respectively) served as controls. (D) IFNc did not considerably increase rates of LAMP1 localization to C. trachomatis inclusions in Irga62/2 MEFs,
compared with that in WT cells. Around 300 bacterial inclusions were examined Colocalization expressed as a mean percentage: for each treatment,
number of LAMP1 +ve inclusions / total number of inclusions6100. Scale bar in (A) and (C) represent 40 and 4 mm, respectively. Error bars 6SD, n=3.
doi:10.1371/journal.pone.0004588.g006
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PLoS ONE | www.plosone.org 8 February 2009 | Volume 4 | Issue 2 | e4588remodels a classically non-fusogenic intracellular pathogen
vacuole, stimulating fusion with autophagosomes and directing
the intruder to the lysosomal compartment for destruction.
Autophagy reroutes cytoplasmic material and organelles
internalized into autophagosomes to lysosomes, culminating in
the formation of autolysosomes and degradation of their cargo
[30,32,33]. Similarly, this process can induce pathogen eradica-
tion. Here we showed IFNc stimulates localization of LC3 and the
lysosomal marker LAMP1 to C. trachomatis, but not C. muridarum,
inclusions in WT MEFs. Despite the presence of IFNc,
autophagosome-deficient MEFs were highly permissive to C.
trachomatis replication in a compartment disconnected from
lysosomes, confirming an involvement of autophagy that leads to
lysosomal degradation of the bacteria. Similarly, a study in
macrophages showed that IFNc stimulates recruitment of LC3
and LAMP1 to the M. tuberculosis compartment and induces
autophagy to inhibit bacterial viability [13]. In addition, the
induction of structures carrying LC3 close to disrupting T. gondii
vacuoles in IFN-c-induced astrocytes has been reported [24].
IFNc therefore represents a novel means to counteract the non-
fusogenicity of the C. trachomatis inclusion by remodelling it into a
compartment with autophagic characteristics to prompt fusion
with lysosomes for degradation.
In contrast to our results, a previous study implied that IFNc-
mediated suppression of C. trachomatis in MECs was not the result
of fusion with lysosomes, but due to a reduction of lipid trafficking
to inclusions [28]. This discrepancy can be explained by the fact
that our LAMP1 analysis was done at 3 h p.i., a time at which
most C. trachomatis early inclusions strongly colocalized with
LAMP1. In contrast, Nelson and coworkers examined LAMP1
colocalization to 24 h-old inclusions, which probably represent the
20% of C. trachomatis inclusions that might partially have survived
the IFNc-mediated immunity. Nevertheless, we cannot dismiss a
role for lipid and nutrient, or indeed other vacuolar trafficking in
the IFNc-mediated suppression of Chlamydial growth. For
instance, it has been shown that Irga6 interacts with the
microtubule-binding protein hook3; therefore, it is tempting to
consider that Irga6 participates in the modulation of intracellular
membrane-dependent processes [34,46] like vesicular trafficking
and interactions with the pathogen-containing vacuolar mem-
brane components.
Several studies have implicated the IRG family of proteins in
growth regulation of intracellular pathogens [13,14,19,35]. For
instance, Irga6 is required for resistance against T. gondii in
cultured murine astrocytes by activating vacuole vesiculation [24].
A role for Irga6 in the induction of structures carrying LC3 close
Figure 7. Irga6 plays a role in the regulation of the host autophagic machinery. (A–C) Anti-LC3 immunoblot analysis of total lysates from
uninfected WT, Atg52/2 and Irga62/2 MEFs or from cultures infected for indicated time points. Some uninfected cell cultures were exposed to
100 nM Rapa for 3 h or to 100 U/ml IFNc for 32 h. Other monolayers were pretreated with IFNc for 24 h prior to infection and then infected in the
presence of chemicals. 1–7 indicate the different treatments. Host b-actin was used to control equal loading of proteins. (A) Autophagy is induced by
Rapa and IFNc in WT cells, while infection alone does not stimulate autophagy, as indicated by the amount of LC3-II. (B) Defective autophagy in
Atg52/2 MEFs was observed, indicated by absence of LC3 processing (C) Abolishment of Irga6 apparently impaired autophagy induction. Only very
low amounts of cellular LC3 (LC3-II) can be detected in Irga6-knockout cells, compared to those in WT MEFs. (D)–(E) Quantification of GFP-LC3-
vacoules under different conditions in WT (D) and Irga62/2 MEFs (E) treated as indicated for (A)–(C), 24 h after transfection. Around 100 cells were
examined by immunofluorescence microscopy. Data normalized against control. Data show average numbers per cell within a set cytoplasmic area.
Error bars 6SD, n=3.
doi:10.1371/journal.pone.0004588.g007
Control of Ctr via Irga6
PLoS ONE | www.plosone.org 9 February 2009 | Volume 4 | Issue 2 | e4588to disrupting T. gondii vacuoles upon IFNc-treatment has also been
suggested [24]. Similarly, Irgm3 induces T. gondii vacuole
vesiculation and fusion with autophagosomes in macrophages
activated in vivo [23]. Recently, siRNA targeting of Irga6 was
shown to partially revert the IFNc-induced growth inhibition of C.
trachomatis, whereas siRNA-mediated knockdown of Irgb6, Irgd,
Irgm1, Irgm2 or Irgm3 did not [28]. In support of these data, we
uncover Irga6 as a major effector protein in IFNc-induced
elimination of C. trachomatis. Despite an accumulation of other IRG
members at the C. trachomatis inclusion in Irga62/2 cells, C.
trachomatis grow more efficiently than in WT MEFs. Similarly, an
analysis of isolated Irga62/2 astrocytes showed a significant loss
of resistance to T. gondii, even though Irgb6, Irgd, Irgm2 and
Irgm3 still localized to the parasitophorous vacuole [24].
Additionally, C. trachomatis inclusions in Irga62/2 cells do not
colocalize with LAMP1 and LC3, confirming an involvement of
autophagy in restricting pathogen growth. In T. gondii, it has been
proposed that autophagic sequestration follows damage to the
vacuolar membrane containing the organism [23], but it is not yet
known whether such damage or a molecular modification of the
target membrane leads to autophagic uptake. The present study
clearly shows that molecular remodelling of the chlamydial
inclusion membrane in response to IFNc stimulation promotes
fusion with autophagosomes.
There is some evidence that GMS subfamily proteins (Irgm1,
Irgm2 and Irgm3) are required for the normal function of Irga6
[16]. When overexpressed in cells not stimulated with IFNc, Irga6
and Irgb6 intracellularly mislocalized and aggregated. This
mislocalization could be corrected by co-expression of Irgm1,
Irgm2 and Irgm3. Another line of evidence shows that IRG
proteins accumulate on the T. gondii vacuole in a cooperative
manner to regulate anti-parasitic Irga6 function [36]. The
assembly of Irga6, Irgb6, Irgd, Irgm2 and Irgm3 on C. trachomatis
inclusions in WT MEFs and the lack of Irgm1 colocalization
observed in this study is largely consistent with IRGs after infection
of murine astrocytes with T. gondii [24]. The function of Irgm1,
however, does not necessarily require its direct association with the
microbial vacuole. Indeed, Irgm1-deficient mice are susceptible to
C. trachomatis [37], T. gondii [38], T. cruzi [39] and M. tuberculosis
[19] infection. The role of the other IRGs may be to induce the
accumulation of effective Irga6 concentrations and/or its correct
positioning for autophagosome remodelling. Recent work has
demonstrated an essential role for Atg5, independent of autoph-
agy, in trafficking Irga6 to vacuole membranes of T. gondii and
subsequent pathogen clearance [40]. Here, we also found
recruitment of Irga6 was linked to Atg5, in an autophagy
dependent manner, as accumulation of Irga6 at early chlamydial
inclusions was blocked in Atg52/2 MEFs. Future experiments
will define the importance of these factors in recruitment of Irga6
to the inclusion and its antimicrobial function.
The inhibitory effects of IFNc on chlamydial replication have
been extensively studied, revealing marked inconsistencies in
chlamydial strain susceptibility and antichlamydial effector
mechanisms, as demonstrated by discrepancies in the role of
IRGs in controlling chlamydial infections. Both Irgm3 and Irgb10
were found to mediate resistance to C. trachomatis in cultures and in
systemically infected mice [20]. Irgm2 and Irgb10 have been
implicated in C. psittaci resistance in cell cultures and locally
infected mice [41]. In agreement with our study, Nelson and co-
workers suggested a crucial role for Irga6 in C. trachomatis growth
control [28]. In contrast, it was recently shown that Irga62/2
MEFs are not defective, but more efficient in restricting growth of
C. trachomatis compared with control IFNc-treated MEFs [37].
Subcellular localization studies only partly agree with our data,
showing Irga6 localization and the absence of Irgm1 localization
to inclusions upon IFNc stimulation [20]. Also, Bernstein-Hanley
and coworkers detected no Irgm3 at the C. trachomatis inclusion and
the bacterium’s growth in systemically infected mice was not
affected; it remains unclear why resistance is not affected in
Irga62/2 mice. More specific infection of the uterine mucosa by
intrauterine inoculation with human chlamydial strains, as
previously described [42], might lead to a more coherent outcome.
Overall, these studies point to the complexity and diversity of
IRGs that participate in host resistance mechanisms. The
pleiotropic signaling capabilities and host and tissue specificities
of IFNc [43], the genomic differences among chlamydial strains
studied [44,45], differences in susceptibility among inbred mouse
strains and the inherent experimental variation between labora-
tories, may account for these discrepancies.
It is indisputable that C. muridarum possesses a very effective
mechanism to evade the murine IFNc response, unlike C.
trachomatis; however, the underlying mechanism remains largely
hypothetical. Nelson and co-workers suggested a gene in the
plasticity zone of C. muridarum, which is absent in C. trachomatis,i s
responsible for avoiding the Irga6-mediated growth inhibition by
C. muridarum in murine cells [28]. This gene encodes a relatively
large protein with a homology to a clostridial toxin and the Yersinia
YopT virulence factor. YopT acts as cysteine protease that can
inactivate Rho GTPase by the cleavage of the GTPase and its
subsequent release from the membrane. Although indirect, the
authors suggested that a C. muridarum hypothetical large toxin
inactivates Irga6 by a similar mechanism. In contrast to our work,
a recent study demonstrated the transient overexpression of Irgb10
in the absence of IFNc was sufficient to reduce the yield of C.
trachomatis, but not C. muridarum [37]. Overexpressed Irgb10 was
found associated with C. trachomatis inclusions only. Based on this
differential subcellular localization of Irgb10 in infected cells, the
authors proposed Irgb10 is recruited to the inclusion to induce
bacterial growth blockage. They also suggested that C. muridarum is
protected from IFNc-induced immune response by a mechanism
that restricts access of Irgb10 to its inclusion. Here we show IFNc-
stimulated association of different IRG proteins (Irga6, Irgb6, Irgd,
Irgm2 and Irgm3) with inclusions harbouring C. trachomatis, but
not C. muridarum. Importantly, Irga6 was found to be the critical
effector protein responsible for immune resistance to C. trachomatis,
while other IRGs could have cooperative interactions. Cells
deficient in Irga6 were highly permissive to C. trachomatis infection,
although other IRGs were recruited in response to IFNc.
However, C. muridarum inclusions did not associate with any of
these IRGs. These results strongly indicate that C. muridarum can
prevent, by a yet undefined mechanism, not only the access and/
or the activity of the effector Irga6, but also the localization of the
so called ‘co-operative’ IRGs required for the anti-bacterial
function of Irga6.
Our data indicate that modification of the inclusion is critical to
the outcome of the host-parasite interaction; the presence of Irga6
on the inclusion membrane defeats the complex array of processes
by which C. trachomatis seeks to delay phagosomal maturation.
Further work will now unravel the precise mechanism(s) through
which Irga6 promotes IFNc -induced C. trachomatis elimination




RPMI-1640 medium and Dulbecco’s minimal essential medium
(DMEM) were purchased from Gibco-Invitrogen (Karlsruhe,
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(Darmstadt, Germany). IFNc was purchased from Strathmann
Biotec Gmbh. (Hamburg, Germany). Bafilomycin A1 (Baf A1) was
purchased from Calbiochem. Rapamycin (Rapa) was obtained
from Sirolimus LC Laboratories (Massachusetts, USA). Goat
antibodies raised against mouse Irgb6 (clone A-20), Irgm2 (clone
L-15), Irgm3 (clone Y-16), and Irgm1 (clone A-19), in addition to
the rabbit antibody against mouse Irgd (clone M-85), were
purchased from Santa Cruz Biotechnology, Inc. (Heidelberg,
Germany). Other serological reagents used were: monoclonal anti-
mouse Irga6 antibody raised in mice (clone 10D7 [46]), rat anti-
mouse lysosomal associated membrane protein 1 (LAMP1) (clone
1D4B; Abcam, Cambridge, UK), monoclonal antibody to light
chain 3 (LC3) (clone 5F10; purchased from nanoTools, Teningen,
Germany), mouse monoclonal anti-human b-actin (Sigma-Al-
drich), rabbit polyclonal anti-Chlamydia genus-specific antibody
(Milan Analytica AG, La Roche, Switzerland), and mouse
monoclonal anti-C. trachomatis hsp60 (Alexis, Loerrach, Germany)
and LPS (clone CF6J12, Abcam, Cambridge, UK). The IMAGEN
kit for detection of Chlamydia was from DAKO (Hamburg,
Germany). Secondary labeled antibodies for immunofluorescence
and Western analyses were purchased from Molecular Probes-
MoBiTech (Goettingen, Germany), Dianova (Hamburg, Ger-
many), BD Biosciences-Pharmingen (Heidelberg, Germany), or
Amersham (NJ, USA).
Chlamydia trachomatis and C. muridarum propagation
and murine cell cultures
C. trachomatis Lymphogranuloma venereum (LGV) serovar L2
and C. muridarum, a generous gift from Konrad Sachse (Friedrich-
Loeffler-Institut, Federal Research Institute for Animal Health,
Jena, Germany) were routinely propagated in HeLa cells grown in
RPMI-1640 medium supplemented with glutamine and 5% fetal
bovine serum (FBS). Chlamydia culturing, preparation of EB stock,
and estimation of inclusion forming units (IFU)/ml were
conducted as previously described [47]. Wild type (WT) MEFs
and autophagy-deficient (Atg5-knockout) MEFs were generously
provided by Noburo Mizushima (Department of Physiology and
Cell Biology, Tokyo Medical and Dental University, Tokyo
Japan). Irga6-lacking MEFs were generated in-house (see below).
MEFs were grown in DMEM provided with 10% FBS, 200 mM
glutamine and 1 mM sodium pyruvate, and incubated at 37uC
and 5% CO2 in a humidified tissue culture chamber.
Infection of MEFs
MEFs were seeded onto 6-well-plates and incubated overnight
to allow adherence. Host cells were then infected with either C.
trachomatis or C. muridarum diluted in cell growth medium at an
MOI of 1 and incubated at 35uC and 5% CO2. Two hours post
infection (p.i.) cells were washed and loaded with fresh medium
containing 100 or 200 U/ml IFNc. Control infected cells were not
treated with the cytokine. Cell cultures were then incubated as
above for 48 h.
Infectivity titration assays
Formation of infectious C. trachomatis and C. muridarum progeny
in a secondary infection was assessed as described elsewhere [47].
Briefly, infected cells were mechanically destructed using glass
beads. Lysates were serially diluted in IM and inoculated onto
HeLa cells for 2 h. Cells were then washed and further incubated
for 24 h in RPMI medium with 5% FBS and 1 mg/ml
cycloheximide. Chlamydial inclusions were fixed with methanol
and then immunostained with IMAGEN Chlamydia kit. Subse-
quently, inclusions were visualized and counted using immuno-
fluorescence microscopy (Nikon), and infectivity of progeny was
expressed as IFU/ml.
Generation of Irga6-deficient MEFs
MEFs were prepared as described previously [48]. Briefly,
embryos generated from Irga62/26C57BL/6 and Irga62/
26Irga62/2 crosses were isolated on day 13.5 of development.
Placenta, membranes, visceral tissues and the head were removed
from embryos and the remaining tissue was minced and
trypsinized to produce single cells. Single cells were passaged
twice in DMEM containing 10% FBS and then stored in liquid
nitrogen for later use.
Transfection of host cells
MEFs were seeded onto coverslips in 12-well-plates and
incubated overnight at 37uC and 5% CO2 to allow adherence.
MEFs were then washed once and transfected with 1 mg/ml
plasmid DNA encoding pEGFP-rat LC3 (a kind gift from
Tamotsu Yoshimori, Department of Cellular Regulation, Re-
search Institute for Microbial Diseases, Osaka University, Osaka,
Japan), using Lipofectamine 2000 (Gibco-Invitrogen) according to
manufacturer’s instructions. One day post-transfection, cells were
stimulated for 24 h with 100 U/ml IFNc or left unstimulated
(control cells) and incubated in a humidified cell culture incubator.
Next, transfected cells were infected with C. trachomatis or C.
muridarum at a MOI of 5 and incubated for time periods as
indicated at 35uC and 5% CO2, before processing for confocal
microscopy and Western blotting. For colocalization studies MEFs
were stained 3 h p.i. (MOI 5), facilitating the detection of a large
number of intracellular bacteria before eradication in response to
IFNc.
Fluorescence confocal microscopy
MEFs were plated onto coverslips in 12-well-plates at a density
of 2610
5 cells per well and incubated overnight. Next, cells were
treated with 100 U/ml IFNc for 24 h before infection or left
untreated as a control. MEFs were then inoculated with C.
trachomatis at a MOI of 5 and incubated at 35uC and 5% CO2.
Two hours p.i., cells were washed, provided with fresh medium
with or without IFNc, and incubated as before. At indicated time
points, cells were fixed and permeabilized with ice-cold methanol
for 5 min at room temperature (RT). In some experiments, cells
were fixed for 25 min with 4% paraformaldehyde at RT,
permeabilized with either 0.2% saponin, 0.3% Triton-1006 or
digitonin and blocked using 2.5% BSA. Cells were sequentially
incubated for 1 h at RT with primary and secondary antibodies.
Then, coverslips were mounted onto glass slides using Mowiol and
examined by Leica TCS-SP laser scanning confocal microscope
equipped with a krypton/argon laser. Photomicrographs were
processed using Adobe Photoshop 6.0 (Adobe Systems) and
Microsoft Power-Point.
Immunoblotting
MEFs were stimulated with IFNc, as indicated above, or with
the classical autophagy inducer Rapa at a concentration of
100 nM for 2 h. In some experiments, unstimulated and IFNc-
stimulated cells were infected with C. trachomatis or C. muridarum for
either 3 or 8 h. Cells were washed with cold PBS, and lysed for
30 min on ice in Triton-1006 lysis buffer (20 mM Tris-HCl;
pH 7.6, 150 mM NaCl, 1% Triton-100X), containing 2 mM
PMSF and complete protease inhibitor cocktail (Roche). The
lysates were then centrifuged at 8,0006g for 10 min. Equal
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sulfate-polyacrylamide gel electrophoresis (PAGE). Protein bands
were transferred electrophoretically onto Immobilon-P polyviny-
lidene difluoride membranes (Millipore, MA, USA). The mem-
branes were blocked with 5% fat-skim milk in TBS (Tris-buffered
saline; pH 7.5), containing 0.05% Tween-20 for 1 h at RT. Next,
membranes were incubated with the monoclonal mouse anti-LC3
(overnight, at 4uC) or anti-b-actin (1 h at RT) diluted in TBS-
0.05% Tween-20. Membranes were washed and then incubated
with secondary antibodies conjugated with horseradish peroxidase.
Signal detection was performed with the enhanced chemilumi-
nescence system (ECL, Amersham).
Inhibition of lysosomal acidification
MEFs were seeded onto coverslips and exposed to IFNc for
23 h. MEFs were pretreated with 100 nM Baf A1 for 1 h before
the infection. Cells were then inoculated with C. trachomatis (MOI
of 5), and continuously incubated with Baf A1 throughout the
experiment period. Control cell monolayers were treated with
dimethylsulfoxide, in which Baf A1 was dissolved. Specimens were
then fixed and double stained for LAMP1 and C. trachomatis. The
percentages of colocalization of chlamydial inclusions with
LAMP1 were determined in the presence or absence of the
inhibitor.
To examine the effect of the acidification inhibition on the
recovery of infectious chlamydial progeny, cells were grown in 6-
well-plates, treated, and infected as mentioned above. Cells were
then harvested 2 days p.i., lysed and diluted, and formation of
infectious C. trachomatis was assessed by infectivity titration assays
on fresh HeLa cell cultures.
Assessment of host cell viability
Lactate dehydrogenase (LDH) colorimetric assay (Roche
Diagnostics, Mannheim, Germany) was used according to
manufacturer’s instructions. This assay is based on the measure-
ment of LDH activity released from the cytosol of damaged cells
into the supernatant.
Supporting Information
Figure S1 No colocalization of Irga6, Irgb6, Irgd, Irgm1, Irgm2
and Irgm3 at early C. muridarum inclusions upon IFNc stimulation.
Double immunofluorescence labelling of IRGs and C. muridarum in
WT (A), Atg5 2/2 (B) and Irga62/2 (C) MEFs stimulated for
24 h with 100 U/ml IFNc and then infected for 3 h with C.
muridarum (MOI 5). IFNc untreated MEFs were similarly infected.
Upon IFNc induction all tested IRGs except Irgb6 were highly
expressed in all cell lines (no Irga6 in Irga6 2/2 MEFs) without
any colocalization to bacterial inclusions. Scale bar represents
5 mm
Found at: doi:10.1371/journal.pone.0004588.s001 (2.84 MB TIF)
Figure S2 IFNc cannot induce autolysosomal fusion with early
C. muridarum inclusions to suppress bacterial growth in WT,
Atg52/2 and Irg62/2 MEFs. (A) C. muridarum inclusions avoid
interaction with lysosomes in all MEFs tested despite IFNc
induction. IFNc treated and untreated Irga6, Atg52/2 and WT
MEFs were infected with C. muridarum as in Fig. 3A and B. (B)
Quantification of LAMP1-positive chlamydial inclusions revealed
insignificant colocalization rates. Percentage of colocalization
depicted. Error bars 6SD, n=3. (C) No maturation of bacterial
inclusions into autophagosomes. WT, Irga62/2 and Atg52/2
MEFs were first transfected for 24 h with the autophagosome
membrane marker GFP-LC3 and then exposed to 100 U/ml
IFNc for an additional 24 h. Next, cells were infected with C.
muridarum (MOI 5) for 8 h. IFNc-untreated control cells were
similarly infected 48 h post-transfection. LC3 (green) bacterial
inclusions (red) with very low processing for the LC3 (D)
Quantification of GFP-LC3-positive C. muridarum inclusions
demonstrate insignificant colocalization rates among different
treatments. For quantification of both LAMP1 and GFP-LC3 +ve
inclusions, around 300 inclusions were examined. Colocalization
expressed as a mean percentage: number of GFP-LC3 +ve or
LAMP1 +ve inclusions, respectively / total number of inclusions
6100. Error bars 6SD, n=3. Scale bar represents 5 mm
Found at: doi:10.1371/journal.pone.0004588.s002 (1.37 MB TIF)
Figure S3 Irgd, Irgm2, Irgm3, Irgb6 and Irgm1 show a similar
interaction pattern with C. trachomatis early inclusions in Irga6-
knockout MEFs under stimulation with IFNc. Irga6-deficient cells
were exposed to the cytokine, infected with the pathogen, and
stained for Chlamydia and IRGs exactly as described in the legend
to Fig. 2. Untreated knockout cells were infected and stained in
parallel for comparison reasons. (A) Confocal micrographs
showing the double labelling of cells with antibodies against the
pathogen and different IRGs. (B) Quantification of IRG
colocalization with C. trachomatis inclusions. Around 300 bacterial
inclusions examined. Colocalization expressed as a mean percent-
age: number of IRG +ve inclusions / total number of inclusions
6100. Error bars 6SD, n=3. Scale bar represents 5 mm.
Found at: doi:10.1371/journal.pone.0004588.s003 (0.67 MB TIF)
Figure S4 Irga6 does not play a role in the regulation of the host
autophagic machinery during C. muridarum infection. (A–C) Anti-
LC3 immunoblot analysis of total lysates from uninfected WT,
Atg52/2 and Irga62/2 MEFs or from cultures infected for
indicated time points. Some uninfected cell cultures were exposed
to 100 nM Rapa for 3 h or to 100 U/ml IFNc for 32 h. Other
monolayers were pretreated with IFNc for 24 h prior to infection
and then infected in the presence of chemicals. 1–7 indicate the
different treatments. Autophagy induction is reflected by the
increased cellular level of LC3 and formation of autophagosome-
associated LC3-II. Host b-actin was used to control equal loading
of proteins. After infection with C. muridarum, LC3 II level increases
but to a less extent than C. trachomatis (Fig. 7) in IFNc treated (A)
WT cells. LC3 levels do not increase in IFNc treated (C) Irga62/
2 cells. (B) Defective autophagy in Atg52/2 MEFs was observed,
indicated by absence of LC3 processing.
Found at: doi:10.1371/journal.pone.0004588.s004 (0.39 MB TIF)
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